cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Relay Therapeutics Inc
8 own
4 watching
Current Price
$10.57
$0.09
(0.86%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,164.86M
52-Week High
52-Week High
19.54000
52-Week Low
52-Week Low
5.95000
Average Volume
Average Volume
0.73M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,164.86M
icon52-Week High19.54000
icon52-Week Low5.95000
iconAverage Volume0.73M
iconDividend Yield--
iconP/E Ratio--
What does the Relay Therapeutics Inc do?
We are a clinical-stage precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. We were incorporated under the laws of the State of Delaware on May 4, 2015 under the name "Allostery, Inc." Our principal corporate office is located at 399 Binney Street, 2nd Floor, Cambridge, MA 02139, and our telephone number is (617) 370-8837. Our website address is www.relaytx.com.
Read More
How much money does Relay Therapeutics Inc make?
News & Events about Relay Therapeutics Inc.
Benzinga
10 months ago
Latest Ratings for RLAY DateFirmActionFromTo Feb 2022BerenbergInitiates Coverage OnBuy Aug 2021HC Wainwright & Co.MaintainsBuy Jul 2021B of A SecuritiesInitiates Coverage OnBuy View More Analyst Ratings for RLAY View the Latest Analyst Ratings read more...
Globe Newswire
10 months ago
Multiple doses achieved sustained target exposure of ~80%+ mutant PI3K inhibition No Grade 3 hyperglycemia, rash or diarrhea observed at target exposures Favorable initial safety profile at target exposures Confirmed partial response in breast cancer patient with 12 prior lines of therapy Initial ...
PR Newswire
11 months ago
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire VANCOUVER, British Columbia, March 24, 2023 FN Media Group Presents USA News Group News Commentary VANCOUVER...
Globe Newswire
11 months ago
Relay Therapeutics to host conference call following AACR presentationCAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and ...
Globe Newswire
11 months ago
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in two fireside chats this month, at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 10:30 a.m. ET and the Barclays Global Healthcare Conference on ...
Frequently Asked Questions
Frequently Asked Questions
What is Relay Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Relay Therapeutics Inc shares?
plus_minus_icon
How can I buy Relay Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Relay Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Relay Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Relay Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Relay Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Relay Therapeutics Inc?
plus_minus_icon
What percentage is Relay Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Relay Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.57
$0.09
(0.86%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00